The aim of this study was to compare blood sugar control and weight loss in patients with type 2 diabetes (T2D) who were treated with canagliflozin compared to sitagliptin. The main finding was that patients treated with canagliflozin had better blood sugar control and greater weight loss than those treated with sitagliptin.

This study investigated the mortality rates in patients with early rheumatoid arthritis (RA). They found that mortality rates were similar to the general population in these patients.

This trial is comparing the effectiveness of G-Pen (Glucagon Injection) to GlucaGen® Hypokit® (Glucagon) in the treatment of hypoglycemia in patients with type 1 diabetes (T1D). The main outcome to be measured is the number of patients with an increase in blood sugar levels within 30 minutes after rescue medication. 

This study examined how the weather can affect disease activity in patients with rheumatoid arthritis. The authors concluded that increased exposure to sunshine and lower humidity can decrease disease activity in patients with rheumatoid arthritis.

The aim of this study was to investigate if reducing basal insulin rate (BRR) 90-minutes before exercise was better at preventing hypoglycemia (dangerously low blood glucose) than suspending the insulin pump (pump suspension; PS) in type 1 diabetes (T1D). The main finding was that BRR 90-minutes before exercise improved blood glucose control and reduced hypoglycemia compared to PS.

The aim of this study is to evaluate the effect of the DASH (dietary approaches to stop hypertension) diet on heart disease, blood pressure and diabetes in patients with and without diabetes. The main finding of this study was that the DASH diet is associated with a decreased risk of heart disease and improves blood pressure in patients with and without diabetes.

This study examined the long-term safety and effectiveness of abatacept (Orencia) and whether methotrexate (Trexall) enhances its effect.

This paper studied how physical activity is related to fatigue in patients with rheumatoid arthritis (RA).

This study aimed to investigate the effects of resveratrol on diabetic kidney disease. The main finding of the study was that resveratrol reduced the amount of protein lost in the urine in diabetic kidney disease.

This study aimed to investigate the effect of canagliflozin (Invokana) use on bone fracture risk in patients with type 2 diabetes (T2D). The main finding of the study was that there was no increased risk of bone fractures with canagliflozin use.